Live feed12:00:00·354dPRReleasevia QuantisnowChemDiv Extends CMC Services Collaboration for Ratutrelvir, a Potential Best-in-Class COVID-19 Therapeutic Advancing in Phase 2 Clinical TrialsByQuantisnow·Wall Street's wire, on your screen.TRAW· Traws Pharma Inc.Health Care